ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000234694.1	ABT-263 (navitoclax)	Bladder urothelial carcinoma	0.013297858	Resistant
ENSG00000234694.1	ABT-263 (navitoclax)	Breast invasive carcinoma	0.046090316	Sensitive